{"transactions":[{"id":4633840,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-03T00:27:48.000Z","date":"2026-09-30","kind":"purchase","planned":false,"acquired":true,"shares":10,"price":297.43,"value":2974.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were acquired pursuant to the Company's Employee Stock Purchase Plan at the fair market value of the Company's common stock on the purchase date.  The Reporting Person elected to participate in the Plan during an open trading window prior to the commencement of the quarterly purchase period."}],"balance_after":27762,"source":{"system":"sec-edgar","filing":"0001100682-26-000144","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000144/form4.xml","form_type":"4"}},{"id":755534,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:46:05.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":6640,"price":180.71,"value":1199914.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units annually ratably vest on May 29, 2027; May 29, 2028; May 29, 2029; and May 29, 2030."}],"balance_after":27752,"source":{"system":"sec-edgar","filing":"0001100682-26-000101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000101/form4.xml","form_type":"4"}},{"id":794318,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-04T21:16:29.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":21112,"price":165.78,"value":3499947.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units annually ratably vest on: May 1, 2027; May 1, 2028; May 1, 2029; and May 1, 2030."}],"balance_after":21112,"source":{"system":"sec-edgar","filing":"0001100682-26-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000033/form4.xml","form_type":"4"}},{"id":986892,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & CFO"}}],"security":"Class A Common Stock","published_at":"2025-11-26T15:45:01.000Z","date":"2025-11-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects the cancellation at the Effective Time of RSUs granted to the reporting person on or after August 16, 2025. Pursuant to the Merger Agreement, these RSUs were cancelled in connection with the Merger for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the cancellation at the Effective Time of RSUs granted to the reporting person on or after August 16, 2025. Pursuant to the Merger Agreement, these RSUs were cancelled in connection with the Merger for no consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-299012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434369/000119312525299012/ownership.xml","form_type":"4"}},{"id":986891,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & CFO"}}],"security":"Class A Common Stock","published_at":"2025-11-26T15:45:01.000Z","date":"2025-11-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":161464,"price":28.25,"value":4561358.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of shares of Class A Common Stock, par value $0.01 per share (\"Common Stock\") of Premier, Inc. (\"Issuer\") pursuant to the consummation of the transactions contemplated by the Agreement and Plan of Merger dated as of September 21, 2025 (the \"Merger Agreement\") by and among the Issuer, Premium Parent, LLC (\"Parent\") and Premium Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, at the effective time of the Merger on November 25, 2025 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). At the Effective Time, each issued and outstanding share of Common Stock was cancelled and converted automatically into the right to receive $28.25 in cash, without interest (the \"Merger Consideration\"), subject to certain exceptions set forth in the Merger Agreement."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of the Issuer's Common Stock reported as disposed of by the reporting person include shares of Common Stock underlying outstanding time-based vesting restricted stock unit awards previously reported as beneficially owned by the reporting person (\"RSUs\") and granted to the reporting person prior to August 16, 2025. Pursuant to the Merger Agreement, at the Effective Time, each of these RSUs was cancelled and converted into the right to receive an amount in cash, without interest, equal to the number of shares of Common Stock subject to the RSUs multiplied by the Merger Consideration (together with any accrued cash dividend equivalents)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of Class A Common Stock, par value $0.01 per share (\"Common Stock\") of Premier, Inc. (\"Issuer\") pursuant to the consummation of the transactions contemplated by the Agreement and Plan of Merger dated as of September 21, 2025 (the \"Merger Agreement\") by and among the Issuer, Premium Parent, LLC (\"Parent\") and Premium Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, at the effective time of the Merger on November 25, 2025 (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). At the Effective Time, each issued and outstanding share of Common Stock was cancelled and converted automatically into the right to receive $28.25 in cash, without interest (the \"Merger Consideration\"), subject to certain exceptions set forth in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of the Issuer's Common Stock reported as disposed of by the reporting person include shares of Common Stock underlying outstanding time-based vesting restricted stock unit awards previously reported as beneficially owned by the reporting person (\"RSUs\") and granted to the reporting person prior to August 16, 2025. Pursuant to the Merger Agreement, at the Effective Time, each of these RSUs was cancelled and converted into the right to receive an amount in cash, without interest, equal to the number of shares of Common Stock subject to the RSUs multiplied by the Merger Consideration (together with any accrued cash dividend equivalents)."}],"balance_after":32018,"source":{"system":"sec-edgar","filing":"0001193125-25-299012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434369/000119312525299012/ownership.xml","form_type":"4"}},{"id":1001906,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & CFO"}}],"security":"Class A Common Stock","published_at":"2025-11-12T20:53:02.000Z","date":"2025-11-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":3874,"price":28.17,"value":109130.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the number of shares of the issuer's Common Stock that were withheld to cover tax liability in connection with vesting and settlement of stock unit grants reported on a prior Form 4."}],"balance_after":193482,"source":{"system":"sec-edgar","filing":"0001193125-25-277429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434369/000119312525277429/ownership.xml","form_type":"4"}},{"id":1001905,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & CFO"}}],"security":"Class A Common Stock","published_at":"2025-11-12T20:53:02.000Z","date":"2025-11-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":17026,"price":28.17,"value":479622.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the number of shares of the issuer's Common Stock that were withheld to cover tax liability in connection with vesting and settlement of stock unit grants reported on a prior Form 4."}],"balance_after":197356,"source":{"system":"sec-edgar","filing":"0001193125-25-277429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434369/000119312525277429/ownership.xml","form_type":"4"}},{"id":1057730,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & CFO"}}],"security":"Class A Common Stock","published_at":"2025-08-22T17:11:31.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":32018,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":214382,"source":{"system":"sec-edgar","filing":"0001434369-25-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434369/000143436925000003/ownership.xml","form_type":"4"}},{"id":1060144,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & CFO"}}],"security":"Class A Common Stock","published_at":"2025-08-20T22:15:46.000Z","date":"2025-08-19","kind":"grant","planned":false,"acquired":true,"shares":23888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Performance Share Awards allocated to the reporting person based on the issuer's fiscal year 2025 financial performance against fiscal year 2025 performance metrics for those awards, but which will not vest until after the end of a three year performance cycle subject to continued employment."}],"balance_after":182364,"source":{"system":"sec-edgar","filing":"0000950170-25-110504","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434369/000095017025110504/ownership.xml","form_type":"4"}},{"id":1060143,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & CFO"}}],"security":"Class A Common Stock","published_at":"2025-08-20T22:15:46.000Z","date":"2025-08-19","kind":"grant","planned":false,"acquired":true,"shares":15001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Performance Share Awards allocated to the reporting person based on the issuer's fiscal year 2025 financial performance against fiscal year 2025 performance metrics for those awards, but which will not vest until after the end of a three year performance cycle subject to continued employment."}],"balance_after":158476,"source":{"system":"sec-edgar","filing":"0000950170-25-110504","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434369/000095017025110504/ownership.xml","form_type":"4"}},{"id":1368743,"issuer":{"id":72504,"kind":"organization","name":"Premier, Inc.","symbol":"PINC"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO & CFO"}}],"security":"Class A Common Stock","published_at":"2024-11-12T20:23:04.000Z","date":"2024-11-11","kind":"grant","planned":false,"acquired":true,"shares":143475,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":143475,"source":{"system":"sec-edgar","filing":"0000950170-24-125221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434369/000095017024125221/ownership.xml","form_type":"4"}},{"id":1387240,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Phantom Stock (Supplemental Executive Retirement Plan) SERP","published_at":"2024-10-15T20:30:13.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":12.2776,"price":24.5,"value":300.8012,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment."},{"field":"shares","element":"transactionShares","label":"F3","text":"Comprised of phantom stock acquired as a result of accrued dividends."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment."}],"balance_after":1892.0687,"derivative":{"underlying":"Common Stock","underlying_shares":12.2776},"source":{"system":"sec-edgar","filing":"0001127602-24-025499","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760224025499/form4.xml","form_type":"4"}},{"id":1387239,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2024-10-15T20:30:13.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":375.279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis."}],"balance_after":89767.654,"source":{"system":"sec-edgar","filing":"0001127602-24-025499","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760224025499/form4.xml","form_type":"4"}},{"id":1454956,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Phantom Stock (Supplemental Executive Retirement Plan) SERP","published_at":"2024-07-15T20:40:27.000Z","date":"2024-07-12","kind":"grant","planned":false,"acquired":true,"shares":11.5859,"price":25.8,"value":298.91622,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Comprised of phantom stock acquired as a result of accrued dividends."}],"balance_after":1879.7911,"derivative":{"underlying":"Common Stock","underlying_shares":11.5859},"source":{"system":"sec-edgar","filing":"0001127602-24-020387","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760224020387/form4.xml","form_type":"4"}},{"id":1454955,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2024-07-15T20:40:27.000Z","date":"2024-07-12","kind":"grant","planned":false,"acquired":true,"shares":404.918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 236 shares acquired between January 1st - June 30,2024 under the Dentsply Sirona Employee Stock Purchase Plan."}],"balance_after":89392.375,"source":{"system":"sec-edgar","filing":"0001127602-24-020387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760224020387/form4.xml","form_type":"4"}},{"id":1542265,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Phantom Stock (Supplemental Executive Retirement Plan) SERP","published_at":"2024-04-15T23:13:46.000Z","date":"2024-04-12","kind":"grant","planned":false,"acquired":true,"shares":9.4552,"price":31.45,"value":297.36604,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment."},{"field":"shares","element":"transactionShares","label":"F3","text":"Comprised of phantom stock acquired as a result of accrued dividends."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment."}],"balance_after":1868.2052,"derivative":{"underlying":"Common Stock","underlying_shares":9.4552},"source":{"system":"sec-edgar","filing":"0001127602-24-012897","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760224012897/form4.xml","form_type":"4"}},{"id":1542264,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2024-04-15T23:13:46.000Z","date":"2024-04-12","kind":"grant","planned":false,"acquired":true,"shares":302.443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis."}],"balance_after":88751.457,"source":{"system":"sec-edgar","filing":"0001127602-24-012897","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760224012897/form4.xml","form_type":"4"}},{"id":1571115,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Phantom Stock (Supplemental Executive Retirement Plan) SERP","published_at":"2024-03-19T20:55:28.000Z","date":"2024-03-18","kind":"grant","planned":false,"acquired":true,"shares":1858.75,"price":35.59,"value":66152.9125,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment."},{"field":"shares","element":"transactionShares","label":"F2","text":"Comprised of phantom stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Supplemental Executive Retirement Plan (SERP) contribution for the year 2023 based on closing price on 12/29/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment."}],"balance_after":1858.75,"derivative":{"underlying":"Common Stock","underlying_shares":1858.75},"source":{"system":"sec-edgar","filing":"0001127602-24-010634","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760224010634/form4.xml","form_type":"4"}},{"id":1593010,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T21:33:44.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":62800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest in annual one-third (1/3) increments over a three (3) year period ending March 4, 2027."}],"balance_after":62800,"derivative":{"exercise_price":33.28,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":62800},"source":{"system":"sec-edgar","filing":"0001127602-24-008823","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760224008823/form4.xml","form_type":"4"}},{"id":1593009,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2024-03-06T21:33:44.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":18780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending 3/4/2027."}],"balance_after":88449.014,"source":{"system":"sec-edgar","filing":"0001127602-24-008823","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760224008823/form4.xml","form_type":"4"}},{"id":1604950,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2024-03-04T22:55:38.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1683,"price":33.27,"value":55993.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I."}],"balance_after":69669.014,"source":{"system":"sec-edgar","filing":"0001127602-24-008222","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760224008222/form4.xml","form_type":"4"}},{"id":1679500,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2024-01-16T18:45:50.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":193.629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 165 shares acquired between July 1st - December 31, 2023 under the Dentsply Sirona Employee Stock Purchase Plan."}],"balance_after":71352.014,"source":{"system":"sec-edgar","filing":"0001127602-24-001307","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760224001307/form4.xml","form_type":"4"}},{"id":1729949,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2023-11-27T21:28:30.000Z","date":"2023-11-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2461,"price":31.36,"value":77176.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I."}],"balance_after":71105.385,"source":{"system":"sec-edgar","filing":"0001127602-23-028287","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760223028287/form4.xml","form_type":"4"}},{"id":1735447,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2023-11-20T21:10:24.000Z","date":"2023-11-20","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":29.7,"value":297000.0,"ownership":{"direct":true},"balance_after":73566.385,"source":{"system":"sec-edgar","filing":"0001127602-23-027984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760223027984/form4.xml","form_type":"4"}},{"id":1739974,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2023-11-16T21:25:55.000Z","date":"2023-11-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2385,"price":29.32,"value":69928.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I."}],"balance_after":63566.385,"source":{"system":"sec-edgar","filing":"0001127602-23-027596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760223027596/form4.xml","form_type":"4"}},{"id":1760218,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2023-10-16T20:46:01.000Z","date":"2023-10-13","kind":"grant","planned":false,"acquired":true,"shares":268.072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis."}],"balance_after":65951.385,"source":{"system":"sec-edgar","filing":"0001127602-23-025907","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760223025907/form4.xml","form_type":"4"}},{"id":1829121,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2023-07-17T20:54:39.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":228.02,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 86 shares acquired between January 1st - June 30, 2023 under the Dentsply Sirona Employee Stock Purchase Plan."}],"balance_after":65683.313,"source":{"system":"sec-edgar","filing":"0001127602-23-020823","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760223020823/form4.xml","form_type":"4"}},{"id":1918521,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2023-04-18T20:36:06.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":231.492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis."}],"balance_after":65369.293,"source":{"system":"sec-edgar","filing":"0001127602-23-013135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760223013135/form4.xml","form_type":"4"}},{"id":1967283,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-07T21:09:59.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":49700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Options vest in annual one-third (1/3) increments over a three (3) year period ending March 3, 2026."}],"balance_after":49700,"derivative":{"exercise_price":38.74,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":49700},"source":{"system":"sec-edgar","filing":"0001127602-23-009277","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760223009277/form4.xml","form_type":"4"}},{"id":1967282,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2023-03-07T21:09:59.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":16133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending March 3, 2026."}],"balance_after":65137.801,"source":{"system":"sec-edgar","filing":"0001127602-23-009277","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760223009277/form4.xml","form_type":"4"}},{"id":2055132,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2023-01-13T21:36:19.000Z","date":"2023-01-13","kind":"grant","acquired":true,"shares":378.801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis."}],"balance_after":49004.801,"source":{"system":"sec-edgar","filing":"0001127602-23-001395","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760223001395/form4.xml","form_type":"4"}},{"id":2105919,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2022-11-23T15:32:02.000Z","date":"2022-11-22","kind":"grant","acquired":true,"shares":24695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending November 22, 2025."}],"balance_after":48626,"source":{"system":"sec-edgar","filing":"0001127602-22-026304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760222026304/form4.xml","form_type":"4"}},{"id":2113500,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-17T21:19:58.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":74600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Options vest in annual one-third (1/3) increments over a three-year period ending November 15, 2025."}],"balance_after":74600,"derivative":{"exercise_price":31.34,"expiration_date":"2032-11-15","underlying":"Common Stock","underlying_shares":74600},"source":{"system":"sec-edgar","filing":"0001127602-22-025939","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760222025939/form4.xml","form_type":"4"}},{"id":2113499,"issuer":{"id":4448,"kind":"organization","name":"DENTSPLY SIRONA Inc."},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"officer":true,"officer_title":"Executive VP & CFO"}}],"security":"Common Stock","published_at":"2022-11-17T21:19:58.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":23931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending November 15, 2025."}],"balance_after":23931,"source":{"system":"sec-edgar","filing":"0001127602-22-025939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818479/000112760222025939/form4.xml","form_type":"4"}},{"id":2215692,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2022-07-05T20:57:43.000Z","date":"2022-07-01","kind":"tax_withholding","acquired":false,"shares":6666,"price":55,"value":366630.0,"ownership":{"direct":true},"balance_after":34622,"source":{"system":"sec-edgar","filing":"0001209191-22-040765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122040765/doc4.xml","form_type":"4"}},{"id":2302933,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2022-04-06T20:17:49.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":6268,"price":66.04,"value":413938.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":41288,"source":{"system":"sec-edgar","filing":"0001209191-22-023469","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122023469/doc4.xml","form_type":"4"}},{"id":2334194,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-15T20:46:10.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":20023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022."}],"balance_after":20023,"derivative":{"exercise_price":65.11,"expiration_date":"2030-03-11","underlying":"Common Stock","underlying_shares":20023},"source":{"system":"sec-edgar","filing":"0001209191-22-018845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018845/doc4.xml","form_type":"4"}},{"id":2334193,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2022-03-15T20:46:10.000Z","date":"2022-03-13","kind":"tax_withholding","acquired":false,"shares":5338,"price":65.11,"value":347557.18,"ownership":{"direct":true},"balance_after":47556,"source":{"system":"sec-edgar","filing":"0001209191-22-018845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018845/doc4.xml","form_type":"4"}},{"id":2334192,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2022-03-15T20:46:10.000Z","date":"2022-03-13","kind":"tax_withholding","acquired":false,"shares":2902,"price":65.11,"value":188949.22,"ownership":{"direct":true},"balance_after":52894,"source":{"system":"sec-edgar","filing":"0001209191-22-018845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018845/doc4.xml","form_type":"4"}},{"id":2334191,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2022-03-15T20:46:10.000Z","date":"2022-03-13","kind":"tax_withholding","acquired":false,"shares":1424,"price":65.11,"value":92716.64,"ownership":{"direct":true},"balance_after":55.796,"source":{"system":"sec-edgar","filing":"0001209191-22-018845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018845/doc4.xml","form_type":"4"}},{"id":2334190,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2022-03-15T20:46:10.000Z","date":"2022-03-13","kind":"tax_withholding","acquired":false,"shares":775,"price":65.11,"value":50460.25,"ownership":{"direct":true},"balance_after":57220,"source":{"system":"sec-edgar","filing":"0001209191-22-018845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018845/doc4.xml","form_type":"4"}},{"id":2334189,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2022-03-15T20:46:10.000Z","date":"2022-03-12","kind":"tax_withholding","acquired":false,"shares":1770,"price":65.11,"value":115244.7,"ownership":{"direct":true},"balance_after":57995,"source":{"system":"sec-edgar","filing":"0001209191-22-018845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018845/doc4.xml","form_type":"4"}},{"id":2334188,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2022-03-15T20:46:10.000Z","date":"2022-03-12","kind":"tax_withholding","acquired":false,"shares":3706,"price":65.11,"value":241297.66,"ownership":{"direct":true},"balance_after":59765,"source":{"system":"sec-edgar","filing":"0001209191-22-018845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018845/doc4.xml","form_type":"4"}},{"id":2334187,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2022-03-15T20:46:10.000Z","date":"2022-03-12","kind":"tax_withholding","acquired":false,"shares":1107,"price":65.11,"value":72076.77,"ownership":{"direct":true},"balance_after":63471,"source":{"system":"sec-edgar","filing":"0001209191-22-018845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018845/doc4.xml","form_type":"4"}},{"id":2334186,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2022-03-15T20:46:10.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":7119,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":64578,"source":{"system":"sec-edgar","filing":"0001209191-22-018845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018845/doc4.xml","form_type":"4"}},{"id":2399309,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2022-02-14T21:47:29.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":12576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 12, 2021 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2022 at 200% of target, the first anniversary of the grant date."}],"balance_after":57459,"source":{"system":"sec-edgar","filing":"0001209191-22-009337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122009337/doc4.xml","form_type":"4"}},{"id":2399308,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2022-02-14T21:47:29.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":10837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2020 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2022 at 150% of target, the second anniversary of the grant date."}],"balance_after":44883,"source":{"system":"sec-edgar","filing":"0001209191-22-009337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122009337/doc4.xml","form_type":"4"}},{"id":2399307,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2022-02-14T21:47:29.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":5892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2019 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2022 at 150% of target, the third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 373 shares acquired under the Integra Employee Stock Purchase Plan since the date of the reporting person's most recent filing on Form 4."}],"balance_after":34046,"source":{"system":"sec-edgar","filing":"0001209191-22-009337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122009337/doc4.xml","form_type":"4"}},{"id":2527295,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2021-11-03T20:48:00.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":4275,"price":74,"value":316350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":27781,"source":{"system":"sec-edgar","filing":"0001209191-21-062723","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121062723/doc4.xml","form_type":"4"}},{"id":2746000,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-19T20:19:04.000Z","date":"2021-04-16","kind":"exercise","acquired":false,"shares":25658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the stock options vested every first, second, third and fourth anniversaries of the grant date of 5/2/2014."}],"balance_after":0,"derivative":{"exercise_price":19.41,"expiration_date":"2022-05-02","underlying":"Common Stock","underlying_shares":25658},"source":{"system":"sec-edgar","filing":"0001209191-21-027283","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121027283/doc4.xml","form_type":"4"}},{"id":2745999,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2021-04-19T20:19:04.000Z","date":"2021-04-16","kind":"sale","acquired":false,"shares":25658,"price":71.5,"value":1834547.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":32056,"source":{"system":"sec-edgar","filing":"0001209191-21-027283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121027283/doc4.xml","form_type":"4"}},{"id":2745998,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2021-04-19T20:19:04.000Z","date":"2021-04-16","kind":"exercise","acquired":true,"shares":25658,"price":19.41,"value":498021.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":57714,"source":{"system":"sec-edgar","filing":"0001209191-21-027283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121027283/doc4.xml","form_type":"4"}},{"id":2748927,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2021-04-15T20:12:57.000Z","date":"2021-04-14","kind":"sale","acquired":false,"shares":4002,"price":70.5,"value":282141.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":32056,"source":{"system":"sec-edgar","filing":"0001209191-21-026821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121026821/doc4.xml","form_type":"4"}},{"id":2751502,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-12T20:35:01.000Z","date":"2021-04-09","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the stock options vested every first, second, third and fourth anniversaries of the grant date of 5/2/2014."}],"balance_after":25658,"derivative":{"exercise_price":19.41,"expiration_date":"2022-05-02","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-026363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121026363/doc4.xml","form_type":"4"}},{"id":2751501,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2021-04-12T20:35:01.000Z","date":"2021-04-09","kind":"sale","acquired":false,"shares":12500,"price":70,"value":875000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":36058,"source":{"system":"sec-edgar","filing":"0001209191-21-026363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121026363/doc4.xml","form_type":"4"}},{"id":2751500,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2021-04-12T20:35:01.000Z","date":"2021-04-09","kind":"exercise","acquired":true,"shares":12500,"price":19.41,"value":242625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":48558,"source":{"system":"sec-edgar","filing":"0001209191-21-026363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121026363/doc4.xml","form_type":"4"}},{"id":2768616,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-30T21:33:28.000Z","date":"2021-03-29","kind":"exercise","acquired":false,"shares":12500,"price":19.41,"value":242625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to Rule 10b5-1 trading plans previously adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the stock options vested every first, second, third and fourth anniversaries of the grant date of 5/2/2014."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This option was previously reported as covering 24,264 shares at an exercise price of $44.87 per share, but was adjusted pursuant to the antidilution\nprovisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016."}],"balance_after":38158,"derivative":{"exercise_price":19.41,"expiration_date":"2022-05-02","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-023607","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121023607/doc4.xml","form_type":"4"}},{"id":2768615,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2021-03-30T21:33:28.000Z","date":"2021-03-29","kind":"sale","acquired":false,"shares":12500,"price":68.5,"value":856250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to Rule 10b5-1 trading plans previously adopted by the reporting person."}],"balance_after":36058,"source":{"system":"sec-edgar","filing":"0001209191-21-023607","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121023607/doc4.xml","form_type":"4"}},{"id":2768614,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2021-03-30T21:33:28.000Z","date":"2021-03-29","kind":"exercise","acquired":true,"shares":12500,"price":19.41,"value":242625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to Rule 10b5-1 trading plans previously adopted by the reporting person."}],"balance_after":48558,"source":{"system":"sec-edgar","filing":"0001209191-21-023607","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121023607/doc4.xml","form_type":"4"}},{"id":2768613,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2021-03-30T21:33:28.000Z","date":"2021-03-29","kind":"sale","acquired":false,"shares":3000,"price":68.5,"value":205500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to Rule 10b5-1 trading plans previously adopted by the reporting person."}],"balance_after":36058,"source":{"system":"sec-edgar","filing":"0001209191-21-023607","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121023607/doc4.xml","form_type":"4"}},{"id":2787564,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-16T20:09:51.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":20518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/12/2021."}],"balance_after":20518,"derivative":{"exercise_price":68.1,"expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":20518},"source":{"system":"sec-edgar","filing":"0001209191-21-020757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020757/doc4.xml","form_type":"4"}},{"id":2787563,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2021-03-16T20:09:51.000Z","date":"2021-03-13","kind":"tax_withholding","acquired":false,"shares":515,"price":68.1,"value":35071.5,"ownership":{"direct":true},"balance_after":39058,"source":{"system":"sec-edgar","filing":"0001209191-21-020757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020757/doc4.xml","form_type":"4"}},{"id":2787562,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2021-03-16T20:09:51.000Z","date":"2021-03-13","kind":"tax_withholding","acquired":false,"shares":523,"price":68.1,"value":35616.3,"ownership":{"direct":true},"balance_after":39573,"source":{"system":"sec-edgar","filing":"0001209191-21-020757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020757/doc4.xml","form_type":"4"}},{"id":2787561,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2021-03-16T20:09:51.000Z","date":"2021-03-13","kind":"tax_withholding","acquired":false,"shares":990,"price":68.1,"value":67419.0,"ownership":{"direct":true},"balance_after":40096,"source":{"system":"sec-edgar","filing":"0001209191-21-020757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020757/doc4.xml","form_type":"4"}},{"id":2787560,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2021-03-16T20:09:51.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":6807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 385 shares acquired under the Integra Employee Stock Purchase Plan since the date of the reporting person's most recent filing on Form 4."}],"balance_after":41086,"source":{"system":"sec-edgar","filing":"0001209191-21-020757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020757/doc4.xml","form_type":"4"}},{"id":2978459,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2020-11-17T21:13:32.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":2600,"price":56.0255,"value":145666.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $56.00 to $56.14."}],"balance_after":33894,"source":{"system":"sec-edgar","filing":"0001209191-20-058705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120058705/doc4.xml","form_type":"4"}},{"id":2984821,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2020-11-12T21:08:31.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":4400,"price":56.0447,"value":246596.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price shown above represents the weighted average price of the shares sold. The range of sale prices was $56.00 to $56.135."}],"balance_after":36494,"source":{"system":"sec-edgar","filing":"0001209191-20-057912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120057912/doc4.xml","form_type":"4"}},{"id":2984820,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2020-11-12T21:08:31.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":93,"price":55.04,"value":5118.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":40894,"source":{"system":"sec-edgar","filing":"0001209191-20-057912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120057912/doc4.xml","form_type":"4"}},{"id":2984819,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2020-11-12T21:08:31.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":4907,"price":54.3445,"value":266668.4615,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price shown above represents the weighted average price of the shares sold. The range of sale prices was $54.005 to $54.95."}],"balance_after":40987,"source":{"system":"sec-edgar","filing":"0001209191-20-057912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120057912/doc4.xml","form_type":"4"}},{"id":3059178,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & COO"}}],"security":"Common Stock","published_at":"2020-08-13T20:10:42.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":5000,"price":52.2685,"value":261342.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.00 to $53.03."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":45894,"source":{"system":"sec-edgar","filing":"0001209191-20-046586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120046586/doc4.xml","form_type":"4"}},{"id":3207033,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-03-17T20:10:54.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":43746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2020."}],"balance_after":43746,"derivative":{"exercise_price":43.39,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":43746},"source":{"system":"sec-edgar","filing":"0001209191-20-019552","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019552/doc4.xml","form_type":"4"}},{"id":3207032,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2020-03-17T20:10:54.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":2300,"price":43.39,"value":99797.0,"ownership":{"direct":true},"balance_after":50894,"source":{"system":"sec-edgar","filing":"0001209191-20-019552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019552/doc4.xml","form_type":"4"}},{"id":3207031,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2020-03-17T20:10:54.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":1568,"price":43.39,"value":68035.52,"ownership":{"direct":true},"balance_after":53194,"source":{"system":"sec-edgar","filing":"0001209191-20-019552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019552/doc4.xml","form_type":"4"}},{"id":3207030,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2020-03-17T20:10:54.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":1211,"price":43.39,"value":52545.29,"ownership":{"direct":true},"balance_after":54762,"source":{"system":"sec-edgar","filing":"0001209191-20-019552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019552/doc4.xml","form_type":"4"}},{"id":3207029,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2020-03-17T20:10:54.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":8758,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":55973,"source":{"system":"sec-edgar","filing":"0001209191-20-019552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019552/doc4.xml","form_type":"4"}},{"id":3207028,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2020-03-17T20:10:54.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":719,"price":43.39,"value":31197.41,"ownership":{"direct":true},"balance_after":47215,"source":{"system":"sec-edgar","filing":"0001209191-20-019552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019552/doc4.xml","form_type":"4"}},{"id":3207027,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2020-03-17T20:10:54.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":751,"price":43.39,"value":32585.89,"ownership":{"direct":true},"balance_after":47934,"source":{"system":"sec-edgar","filing":"0001209191-20-019552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019552/doc4.xml","form_type":"4"}},{"id":3207026,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2020-03-17T20:10:54.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":883,"price":43.39,"value":38313.37,"ownership":{"direct":true},"balance_after":48685,"source":{"system":"sec-edgar","filing":"0001209191-20-019552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019552/doc4.xml","form_type":"4"}},{"id":3267922,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2020-02-18T21:36:57.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":3697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2019 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the first anniversary of the grant date."}],"balance_after":49568,"source":{"system":"sec-edgar","filing":"0001209191-20-010167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120010167/doc4.xml","form_type":"4"}},{"id":3267921,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2020-02-18T21:36:57.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":3535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the second anniversary of the grant date."}],"balance_after":45871,"source":{"system":"sec-edgar","filing":"0001209191-20-010167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120010167/doc4.xml","form_type":"4"}},{"id":3267920,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2020-02-18T21:36:57.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":6714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019, at least 9% and up to a maximum of 33% cumulative increase in annual revenue over the 2016 fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 34% of the shares will vest on March 13, 2020 at 150% of target, the third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 428 shares acquired under the Integra Employee Stock Purchase Plan since the date of the reporting person's most recent filing on Form 4."}],"balance_after":42336,"source":{"system":"sec-edgar","filing":"0001209191-20-010167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120010167/doc4.xml","form_type":"4"}},{"id":3455521,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2019-07-26T20:12:52.000Z","date":"2019-07-24","kind":"sale","acquired":false,"shares":3500,"price":57.5,"value":201250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":35194,"source":{"system":"sec-edgar","filing":"0001209191-19-043328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119043328/doc4.xml","form_type":"4"}},{"id":3469160,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2019-07-03T18:06:22.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":13534,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38694,"source":{"system":"sec-edgar","filing":"0001209191-19-040848","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119040848/doc4.xml","form_type":"4"}},{"id":3472560,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2019-07-02T20:14:10.000Z","date":"2019-06-28","kind":"sale","acquired":false,"shares":3650,"price":55,"value":200750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":25160,"source":{"system":"sec-edgar","filing":"0001209191-19-040218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119040218/doc4.xml","form_type":"4"}},{"id":3594090,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-03-15T21:18:54.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":20678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, and third anniversaries of the grant date of 3/13/2019."}],"balance_after":20678,"derivative":{"exercise_price":55.91,"expiration_date":"2027-03-13","underlying":"Common Stock","underlying_shares":20678},"source":{"system":"sec-edgar","filing":"0001209191-19-019754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019754/doc4.xml","form_type":"4"}},{"id":3594089,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2019-03-15T21:18:54.000Z","date":"2019-03-14","kind":"tax_withholding","acquired":false,"shares":721,"price":56.14,"value":40476.94,"ownership":{"direct":true},"balance_after":28810,"source":{"system":"sec-edgar","filing":"0001209191-19-019754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019754/doc4.xml","form_type":"4"}},{"id":3594088,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2019-03-15T21:18:54.000Z","date":"2019-03-14","kind":"tax_withholding","acquired":false,"shares":2700,"price":56.14,"value":151578.0,"ownership":{"direct":true},"balance_after":29531,"source":{"system":"sec-edgar","filing":"0001209191-19-019754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019754/doc4.xml","form_type":"4"}},{"id":3594087,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2019-03-15T21:18:54.000Z","date":"2019-03-13","kind":"tax_withholding","acquired":false,"shares":718,"price":55.91,"value":40143.38,"ownership":{"direct":true},"balance_after":32231,"source":{"system":"sec-edgar","filing":"0001209191-19-019754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019754/doc4.xml","form_type":"4"}},{"id":3594086,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2019-03-15T21:18:54.000Z","date":"2019-03-13","kind":"tax_withholding","acquired":false,"shares":856,"price":55.91,"value":47858.96,"ownership":{"direct":true},"balance_after":32949,"source":{"system":"sec-edgar","filing":"0001209191-19-019754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019754/doc4.xml","form_type":"4"}},{"id":3594085,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2019-03-15T21:18:54.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":4621,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33805,"source":{"system":"sec-edgar","filing":"0001209191-19-019754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019754/doc4.xml","form_type":"4"}},{"id":3594084,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2019-03-15T21:18:54.000Z","date":"2019-03-13","kind":"tax_withholding","acquired":false,"shares":1191,"price":55.91,"value":66588.81,"ownership":{"direct":true},"balance_after":29184,"source":{"system":"sec-edgar","filing":"0001209191-19-019754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019754/doc4.xml","form_type":"4"}},{"id":3594083,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2019-03-15T21:18:54.000Z","date":"2019-03-13","kind":"tax_withholding","acquired":false,"shares":2232,"price":55.91,"value":124791.12,"ownership":{"direct":true},"balance_after":30375,"source":{"system":"sec-edgar","filing":"0001209191-19-019754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019754/doc4.xml","form_type":"4"}},{"id":3651163,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2019-02-19T21:49:01.000Z","date":"2019-02-14","kind":"grant","acquired":true,"shares":3261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal  year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date."}],"balance_after":32607,"source":{"system":"sec-edgar","filing":"0001209191-19-011119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119011119/doc4.xml","form_type":"4"}},{"id":3651162,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2019-02-19T21:49:01.000Z","date":"2019-02-14","kind":"grant","acquired":true,"shares":6516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date."}],"balance_after":29346,"source":{"system":"sec-edgar","filing":"0001209191-19-011119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119011119/doc4.xml","form_type":"4"}},{"id":3651161,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2019-02-19T21:49:01.000Z","date":"2019-02-14","kind":"grant","acquired":true,"shares":5481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 554 shares acquired under the Integra Employee Stock Purchase Plan since the date of the reporting person's most recent filing on Form 4."}],"balance_after":22830,"source":{"system":"sec-edgar","filing":"0001209191-19-011119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119011119/doc4.xml","form_type":"4"}},{"id":3847841,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2018-08-10T20:35:29.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":8916,"price":63.0022,"value":561727.6152,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $63 to $63.011."}],"balance_after":16795,"source":{"system":"sec-edgar","filing":"0001209191-18-046236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118046236/doc4.xml","form_type":"4"}},{"id":3946069,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2018-05-04T20:06:12.000Z","date":"2018-05-02","kind":"tax_withholding","acquired":false,"shares":1777,"price":62,"value":110174.0,"ownership":{"direct":true},"balance_after":25711,"source":{"system":"sec-edgar","filing":"0001209191-18-028073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118028073/doc4.xml","form_type":"4"}},{"id":3946068,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2018-05-04T20:06:12.000Z","date":"2018-05-02","kind":"tax_withholding","acquired":false,"shares":4441,"price":62,"value":275342.0,"ownership":{"direct":true},"balance_after":27488,"source":{"system":"sec-edgar","filing":"0001209191-18-028073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118028073/doc4.xml","form_type":"4"}},{"id":3982398,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2018-03-27T21:33:41.000Z","date":"2018-03-23","kind":"tax_withholding","acquired":false,"shares":551,"price":54.15,"value":29836.65,"ownership":{"direct":true},"balance_after":31929,"source":{"system":"sec-edgar","filing":"0001209191-18-021794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118021794/doc4.xml","form_type":"4"}},{"id":3982397,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":42512,"kind":"person","name":"Coleman Glenn","position":1,"cik":"0001434369","reported_name":"Coleman Glenn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2018-03-27T21:33:41.000Z","date":"2018-03-23","kind":"tax_withholding","acquired":false,"shares":937,"price":54.15,"value":50738.55,"ownership":{"direct":true},"balance_after":32480,"source":{"system":"sec-edgar","filing":"0001209191-18-021794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118021794/doc4.xml","form_type":"4"}}],"next_cursor":"2018-03-27T21:33:41.000000Z,3982397"}